Literature DB >> 27987077

Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.

M Leo1, F Maggi2, G R Dottore1, G Casini3, P Mazzetti2, M Pistello2, S Sellari-Franceschini4, M Nardi3, P Vitti1, C Marcocci1, M Marinò5.   

Abstract

OBJECTIVE: One of the hypotheses on the pathogenesis of autoimmune diseases, including Graves' disease (GD) and Graves' orbitopathy (GO), involves bacterial or viral infections. Recently, Epstein-Barr virus (EBV) has been proposed to play a role in the pathogenesis of idiopathic orbital inflammatory pseudotumor (IOIP) in Asians. The aim of the present study was to investigate the possible association of GO with EBV infection/exposure, as compared with IOIP, using serum and tissue samples, as well as primary cultures of orbital fibroblasts.
METHODS: Thirty-one patients were studied, including four with IOIP, ten with GO, nine with GD without GO and eight control patients without IOIP, GD and GO. All patients with IOIP and GO underwent orbital decompression. Control patients underwent palpebral surgery. Fibroadipose orbital tissue samples were collected. Serum anti-EBV antibodies were measured in all patients. EBV-DNA was measured in blood samples, orbital tissue samples and primary cultures of orbital fibroblasts.
RESULTS: Serum assays showed that the vast majority of patients have had a previous exposure to EBV, but no one had an acute infection. EBV-DNA was detected in ~40% of blood samples from GO, GD and control patients, but in none of the IOIP samples. EBV-DNA was not detected in any of the orbital tissue samples tested or in primary cultures of orbital fibroblasts.
CONCLUSIONS: EBV infection does not seem to be associated with GD, GO and IOIP in Caucasians. Whether EBV is involved in IOIP in Asians or other populations remains to be confirmed.

Entities:  

Keywords:  Epstein–Barr virus; Graves’ disease; Graves’ orbitopathy; Idiopathic inflammatory pseudotumor; Thyroid

Mesh:

Substances:

Year:  2016        PMID: 27987077     DOI: 10.1007/s40618-016-0587-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Lack of detection of retroviral particles (HIAP-1) in the H9 T cell line co-cultured with thyrocytes of Graves' disease.

Authors:  A Fierabracci; C P Upton; N Hajibagheri; G F Bottazzo
Journal:  J Autoimmun       Date:  2001-06       Impact factor: 7.094

2.  Absence of retroviral sequences in Graves' disease.

Authors:  M Humphrey; J Mosca; J R Baker; J J Drabick; F E Carr; D S Burke; L Wartofsky; Y Y Djuh; K D Burman
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

3.  Infection and autoimmune thyroid disease.

Authors:  Terry F Davies
Journal:  J Clin Endocrinol Metab       Date:  2008-03       Impact factor: 5.958

4.  Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

Authors:  Luigi Bartalena; Lelio Baldeschi; Alison Dickinson; Anja Eckstein; Pat Kendall-Taylor; Claudio Marcocci; Maarten Mourits; Petros Perros; Kostas Boboridis; Antonella Boschi; Nicola Currò; Chantal Daumerie; George J Kahaly; Gerasimos E Krassas; Carol M Lane; John H Lazarus; Michele Marinò; Marco Nardi; Christopher Neoh; Jacques Orgiazzi; Simon Pearce; Aldo Pinchera; Susanne Pitz; Mario Salvi; Paolo Sivelli; Matthias Stahl; Georg von Arx; Wilmar M Wiersinga
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

Review 5.  An update on the medical treatment of Graves' hyperthyroidism.

Authors:  Michele Marinò; Francesco Latrofa; Francesca Menconi; Luca Chiovato; Paolo Vitti
Journal:  J Endocrinol Invest       Date:  2014-09-04       Impact factor: 4.256

6.  Autoimmune thyroid diseases and Helicobacter pylori: the correlation is present only in Graves's disease.

Authors:  Vincenzo Bassi; Gennaro Marino; Alba Iengo; Olimpia Fattoruso; Crescenzo Santinelli
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

7.  Retrovirus-like sequences in Graves' disease: implications for human autoimmunity.

Authors:  A Ciampolillo; V Marini; R Mirakian; M Buscema; T Schulz; R Pujol-Borrell; G F Bottazzo
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

Review 8.  Diagnosis and classification of Graves' disease.

Authors:  Francesca Menconi; Claudio Marcocci; Michele Marinò
Journal:  Autoimmun Rev       Date:  2014-01-12       Impact factor: 9.754

9.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

Review 10.  Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus.

Authors:  Britta S Möhl; Jia Chen; Karthik Sathiyamoorthy; Theodore S Jardetzky; Richard Longnecker
Journal:  Mol Cells       Date:  2016-04-06       Impact factor: 5.034

View more
  2 in total

1.  A case of drug-induced Graves' Orbitopathy after combination therapy with Tremelimumab and Durvalumab.

Authors:  E Sabini; A Sframeli; M Marinò
Journal:  J Endocrinol Invest       Date:  2018-05-26       Impact factor: 4.256

2.  Orbital pseudotumor as a result of chronic sinusitis in an HIV-positive patient.

Authors:  Mitchell R Gore
Journal:  Clin Case Rep       Date:  2017-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.